REGN- Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 45 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $239.71M | - | |
| CEO | 214.5K | $165.64M | - | |
| VP | 47.8K | $36.93M | - | |
| VP | 29.5K | $22.79M | - | |
| VP | 21.7K | $16.73M | - |
Activity
Buys and sells only
Transactions
10 filings · page 9
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2023 | Stahl Neil | EVP Research And Development | Sale+OE | 11,665 | $840.98 | $9,810,082.23 | -6.6% | -4.6% | +41.0% | |
| Aug 21, 2023 | Bassler Bonnie L59 | Director | Sale+OE | 853 | $829.00 | $707,137.00 | -40.6% | -5.1% | +41.2% | |
| Aug 10, 2023 | Bassler Bonnie L59 | Director | Sale+OE | 853 | $789.00 | $673,017.00 | -40.6% | +3.8% | +42.7% | |
| Aug 1, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $736.59 | $73,659.19 | - | +5.2% | +46.0% | |
| Aug 1, 2023 | McCourt Marion55 | EVP Commercial | Sell | 250 | $744.66 | $186,165.00 | -1.2% | +5.2% | +46.0% | |
| Jul 3, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $716.88 | $71,687.70 | - | +13.9% | +45.5% | |
| Jul 3, 2023 | McCourt Marion55 | EVP Commercial | Sell | 250 | $710.09 | $177,522.50 | -1.2% | +13.9% | +45.5% | |
| Jun 1, 2023 | McCourt Marion55 | EVP Commercial | Sell | 250 | $736.00 | $184,000.00 | -1.2% | +14.2% | +34.1% | |
| Jun 1, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $735.42 | $73,541.52 | - | +14.2% | +34.1% | |
| May 1, 2023 | Ryan Arthur F54 | Director | Sell | 100 | $805.33 | $80,532.94 | - | -8.0% | +10.4% |